Opiant Pharmaceuticals Current Cash

Opiant Pharmaceuticals (OPNT) currently reports a current cash of $35M as of September 2022. That compares with $35M in the prior-year period — up 0.3% year over year. Use the charts on this page to explore Opiant Pharmaceuticals's current cash history and peer comparisons.

Opiant Pharmaceuticals's current cash increased from $35M to $35M — a 0.3% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Opiant Pharmaceuticals reported $35M in current cash as of September 2022. That compares with $35M in the prior-year period — up 0.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $35M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Opiant Pharmaceuticals, and consider following OPNT for alerts when major investors trade the stock.

Opiant Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $35M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OPNT with unrelated industries.